Home / Monoclonal antibody (VEGF inhibitor) / Ranibizumab
Back to Search

Ranibizumab – Uses, Dosage, and Brands in UAE

Brand Name: Ximluci
Strength: 2.3 mg/1 vial | Form: Solution For Injection
Price in UAE: AED 2447.50
Available in UAE pharmacies

About Ranibizumab

Class: | Monoclonal antibody (VEGF inhibitor) Use: | Treatment of neovascular (wet) age-related macular degeneration (AMD), diabetic macular edema (DME), retinal vein occlusion (RVO), and myopic choroidal neovascularization (mCNV) Adult dose: | 0.5 mg (0.05 mL) injected intravitreally once a month; may be adjusted based on clinical response Pediatric dose: | Safety and efficacy not established in pediatric patients; not recommended for use in children Side effects: | Common side effects

Drug Class

Monoclonal antibody (VEGF inhibitor)

Uses & Indications

Treatment of neovascular (wet) age-related macular degeneration (AMD), diabetic macular edema (DME), retinal vein occlusion (RVO), and myopic choroidal neovascularization (mCNV)

Storage Requirements

Store in the refrigerator (2°C to 8°C); do not freeze; protect from light; may be kept at room temperature (up to 25°C) for a maximum of 24 hours prior to use

Manufacturer & Packaging

Manufacturer: STADA ARZNEIMITTEL AG [Bad Vilbel;Germany], Germany

Package Size

1 Vial (0.23 mL) + 1 Filter Needle

Price & Supplier

Price in UAE: AED 2447.50

Dosage Information

Adult Dose

0.5 mg (0.05 mL) injected intravitreally once a month; may be adjusted based on clinical response

Pediatric Dose

Safety and efficacy not established in pediatric patients; not recommended for use in children

Side Effects

Common side effects include conjunctival hemorrhage, eye pain, increased intraocular pressure, and vitreous floaters

Contraindications & Precautions

Hypersensitivity to ranibizumab or any component of the formulation; active ocular or periocular infections

Important Warnings

Risk of endophthalmitis; monitor for signs of intraocular inflammation; potential for arterial thromboembolic events; use caution in patients with a history of thromboembolic disease

Other Brands & Strengths Available in UAE

Different brands and strengths of Ranibizumab available in UAE pharmacies:

LUCENTIS 10 mg/ml Solution For Injection LUCENTIS 10 mg/ml Solution For Injection RAVEGZA 2.3 mg/1 vial Solution For Injection Ximluci 2.3 mg/1 vial Solution For Injection

Related Medicines in Same Category

See also: Other Monoclonal antibody (VEGF inhibitor) medicines available in UAE pharmacies

Bevacizumab Bevacizumab Bevacizumab (ABEVMY) Bevacizumab (ABEVMY) Bevacizumab (MVASI) Bevacizumab (MVASI) Bevacizumab(ZIRABEV) Bevacizumab(ZIRABEV)

Medical Disclaimer

This information is for educational purposes only and should not replace professional medical advice. Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication. The information presented here is specific to medicines available in UAE pharmacies and is regularly updated to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.

View All Monoclonal antibody (VEGF inhibitor) Medicines Browse All Categories